{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:28:21Z","timestamp":1789756101620,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1496-0","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T13:35:34Z","timestamp":1460986534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Nian-Zhang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Quan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,18]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264\u20136.","journal-title":"Clin Microbiol Rev"},{"key":"1496_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/fpd.2010.0795","volume":"8","author":"BT Cenci-Goga","year":"2011","unstructured":"Cenci-Goga BT, Rossitto PV, Sechi P, McCrindle CM, Cullor JS. Toxoplasma in animals, food, and humans: an old parasite of new concern. Foodborne Pathog Dis. 2011;8:751\u201362.","journal-title":"Foodborne Pathog Dis"},{"key":"1496_CR3","first-page":"1","volume-title":"Toxoplasmosis of animals and humans","author":"JP Dubey","year":"2010","unstructured":"Dubey JP. Toxoplasmosis of animals and humans. 2nd ed. Boca Raton: CRC Press Inc; 2010. p. 1\u2013313.","edition":"2"},{"key":"1496_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1756-3305-4-165","volume":"4","author":"P Zhou","year":"2011","unstructured":"Zhou P, Chen ZG, Li HL, Zheng HH, He SY, Lin RQ, Zhu XQ. Toxoplasma gondii infection in humans in China. Parasit Vectors. 2011;4:165.","journal-title":"Parasit Vectors"},{"key":"1496_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-2334-13-101","volume":"13","author":"EZ Gebremedhin","year":"2013","unstructured":"Gebremedhin EZ, Abebe AH, Tessema TS, Tullu KD, Medhin G, Vitale M, Di Marco V, Cox E, Dorny P. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infect Dis. 2013;13:101.","journal-title":"BMC Infect Dis"},{"key":"1496_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/INF.0b013e318134286d","volume":"27","author":"F Kieffer","year":"2008","unstructured":"Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. Risk factors for retinochoroiditis during the first 2\u00a0years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J. 2008;27:27\u201332.","journal-title":"Pediatr Infect Dis J"},{"key":"1496_CR7","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1080\/08035250500251999","volume":"94","author":"L Gras","year":"2005","unstructured":"Gras L, Wallon M, Pollak A, Cortina-Boria M, Evenqard B, Hayde M, Petersen E, Gilbert R. European muliticenter study on congential toxoplasmosis: association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 2005;94:1721\u201331.","journal-title":"Acta Paediatr"},{"key":"1496_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1756-3305-6-227","volume":"6","author":"HH Jiang","year":"2013","unstructured":"Jiang HH, Huang SY, Zhou DH, Zhang XX, Su CL, Deng SZ, Zhu XQ. Genetic characterization of Toxoplasma gondii from pigs from different localities in China by PCR-RFLP. Parasit Vectors. 2013;6:227.","journal-title":"Parasit Vectors"},{"key":"1496_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-3305-5-35","volume":"5","author":"M Wang","year":"2012","unstructured":"Wang M, Wang YH, Ye Q, Meng P, Yin H, Zhang DL. Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China. Parasites Vectors. 2012;5:35.","journal-title":"Parasites Vectors"},{"key":"1496_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pt.2008.01.001","volume":"24","author":"P Zhou","year":"2008","unstructured":"Zhou P, Chen N, Zhang RL, Lin RQ, Zhu XQ. Food-borne parasitic zoonoses in China: perspective for control. Trends Parasitol. 2008;24:190\u20136.","journal-title":"Trends Parasitol"},{"key":"1496_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pt.2010.01.009","volume":"26","author":"SA Elmore","year":"2010","unstructured":"Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol. 2010;26:190\u20136.","journal-title":"Trends Parasitol"},{"key":"1496_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1586\/erv.10.113","volume":"9","author":"EA Innes","year":"2010","unstructured":"Innes EA. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? Expert Rev Vaccines. 2010;9:1117\u20139.","journal-title":"Expert Rev Vaccines"},{"key":"1496_CR13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","volume":"12","author":"NZ Zhang","year":"2013","unstructured":"Zhang NZ, Chen J, Wang M, Petersen E, Zhu XQ. Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines. 2013;12:1287\u201399.","journal-title":"Expert Rev Vaccines"},{"key":"1496_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S003118200000144X","volume":"110","author":"D Buxton","year":"1995","unstructured":"Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology. 1995;110:11\u20136.","journal-title":"Parasitology"},{"key":"1496_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","volume":"104","author":"E Jongert","year":"2009","unstructured":"Jongert E, Roberts CW, Gargano N, Forster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz. 2009;104:252\u201366.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1496_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.exppara.2013.07.013","volume":"135","author":"DF Qu","year":"2013","unstructured":"Qu DF, Han JZ, Du AF. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp Parasitol. 2013;135:234\u20139.","journal-title":"Exp Parasitol"},{"key":"1496_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.exppara.2012.01.001","volume":"130","author":"X Huang","year":"2012","unstructured":"Huang X, Li J, Zhang G, Gong P, Yang J, Zhang X. Toxoplasma gondii: protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BLAB\/c mice. Exp Parasitol. 2012;130:218\u201322.","journal-title":"Exp Parasitol"},{"key":"1496_CR18","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.vaccine.2011.01.089","volume":"29","author":"F Tan","year":"2011","unstructured":"Tan F, Hu X, Luo FJ, Pan CW, Chen XG. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II. Vaccine. 2011;29:2742\u20138.","journal-title":"Vaccine"},{"key":"1496_CR19","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","volume":"29","author":"ZG Yuan","year":"2011","unstructured":"Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, He XH, Zhou DH, He Yong, Li HX, Liao M, Zhu XQ. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine. 2011;29:6614\u20139.","journal-title":"Vaccine"},{"key":"1496_CR20","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1371\/journal.ppat.0030014","volume":"3","author":"H EI Hajj","year":"2007","unstructured":"EI Hajj H, Lebrun M, Arold ST, Vial H, Labesse G, Dubremetz JF. ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog. 2007;3:e14.","journal-title":"PLoS Pathog"},{"key":"1496_CR21","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1126\/science.1133690","volume":"314","author":"JP Saeij","year":"2006","unstructured":"Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, Ajioka JW, Boothroyd JC. Polymorphic secreted kinases are virulence factors in toxoplasmosis. Science. 2006;314:1780\u20133.","journal-title":"Science"},{"key":"1496_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.chom.2009.05.017","volume":"5","author":"O Billker","year":"2009","unstructured":"Billker O, Lourido S, Sibley LD. Calcium-dependent signaling and kinases in apicomplexan parasites. Cell Host Microbe. 2009;5:612\u201322.","journal-title":"Cell Host Microbe"},{"key":"1496_CR23","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/molbev\/msl026","volume":"23","author":"K Nagamune","year":"2006","unstructured":"Nagamune K, Sibley LD. Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa. Mol Biol Evol. 2006;23:1613\u201327.","journal-title":"Mol Biol Evol"},{"key":"1496_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature09022","volume":"465","author":"S Lourido","year":"2013","unstructured":"Lourido S, Shuman J, Zhang C, Shokat KM, Hui R, Sibley LD. Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma. Nature. 2013;465:359\u201362.","journal-title":"Nature"},{"key":"1496_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003066","volume":"8","author":"JM McCoy","year":"2012","unstructured":"McCoy JM, Whitehead L, van Dooren GG, Tonkin CJ. TgCDPK3 regulates calcium-dependent egress of Toxoplasma gondii from host cells. PLoS Pathog. 2012;8, e1003066.","journal-title":"PLoS Pathog"},{"key":"1496_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/1471-2334-14-487","volume":"14","author":"J Chen","year":"2014","unstructured":"Chen J, Li ZY, Huang SY, Petersen E, Song HQ, Zhou DH, Zhu XQ. Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice. BMC Infect Dis. 2014;14:487.","journal-title":"BMC Infect Dis"},{"key":"1496_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/1471-2334-13-512","volume":"13","author":"NZ Zhang","year":"2013","unstructured":"Zhang NZ, Huang SY, Zhou DH, Chen J, Xu Y, Tian WP, Lu J, Zhu XQ. Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3. BMC Infect Dis. 2013;13:512.","journal-title":"BMC Infect Dis"},{"key":"1496_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1128\/CVI.00059-14","volume":"21","author":"NZ Zhang","year":"2014","unstructured":"Zhang NZ, Huang SY, Xu Y, Chen J, Wang JL, Tian WP, Zhu XQ. Evaluation of immune responses in mice after DNA immunization with putative Toxopalsma gondii calcium-dependent protein kinase 5. Clin Vaccine Immunol. 2014;21:924\u20139.","journal-title":"Clin Vaccine Immunol"},{"key":"1496_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1023\/A:1018980020506","volume":"10","author":"H Jeffery","year":"1993","unstructured":"Jeffery H, Davis SS, O\u2019Hagan DT. The preparation and characterization of poly (lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res. 1993;10:362\u20138.","journal-title":"Pharm Res"},{"key":"1496_CR30","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.vaccine.2013.01.027","volume":"31","author":"J Chen","year":"2013","unstructured":"Chen J, Huang SY, Li ZY, Yuan ZG, Zhou D, Petersen E, Zhang NZ, Zhu XQ. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine. 2013;31:1734\u20139.","journal-title":"Vaccine"},{"key":"1496_CR31","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.biomaterials.2013.01.032","volume":"34","author":"AP Acharya","year":"2013","unstructured":"Acharya AP, Lewis JS, Keselowsky BG. Combinatorial co-encapsulation of hydrophobic molecules in poly (lactide-co-glycolide) microparticles. Biomaterials. 2013;34:3422\u201330.","journal-title":"Biomaterials"},{"key":"1496_CR32","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/IAI.66.9.4503-4506.1998","volume":"66","author":"V Letscher-Bru","year":"1998","unstructured":"Letscher-Bru V, Villard O, Risse B, Zauke M, Klein JP, Kien TT. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infect Immun. 1998;66:4503\u20136.","journal-title":"Infect Immun"},{"key":"1496_CR33","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1016\/j.vaccine.2007.02.057","volume":"25","author":"M Golkar","year":"2007","unstructured":"Golkar M, Shokrgozar MA, Rafati S, Musset K, Assmar M, Sadaie R, CesbronDelauw MF, Mercier C. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine. 2007;25:4301\u201311.","journal-title":"Vaccine"},{"key":"1496_CR34","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1016\/j.vaccine.2008.07.031","volume":"26","author":"AF Cuppari","year":"2008","unstructured":"Cuppari AF, Sanchez V, Ledesma B, Frank FM, Goldman A, Angel SO, Martin V. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis. Vaccine. 2008;26:5040\u20135.","journal-title":"Vaccine"},{"key":"1496_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.exppara.2009.06.002","volume":"123","author":"B Dziadek","year":"2009","unstructured":"Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Dlugonska H. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol. 2009;123:81\u20139.","journal-title":"Exp Parasitol"},{"key":"1496_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0168-3659(03)00194-9","volume":"90","author":"VR Sinha","year":"2003","unstructured":"Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261\u201380.","journal-title":"J Control Release"},{"key":"1496_CR37","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10856-009-3727-z","volume":"20","author":"TY Lim","year":"2009","unstructured":"Lim TY, Poh CK, Wang W. Poly (lactic-co-glycolic acid) as a controlled release delivery device. J Mater Sci Mater Med. 2009;20:1669\u201375.","journal-title":"J Mater Sci Mater Med"},{"key":"1496_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.exppara.2013.04.002","volume":"134","author":"SC Chuang","year":"2013","unstructured":"Chuang SC, Ko JC, Chen CP, Du JT, Yang CD. Encapsulation of chimeric protein rSAG1\/2 into poly (lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice. Exp Parasitol. 2013;134:430\u20137.","journal-title":"Exp Parasitol"},{"key":"1496_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-3305-6-34","volume":"6","author":"SC Chuang","year":"2013","unstructured":"Chuang SC, Ko JC, Chen CP, Du JT, Yang CD. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB\/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. Parasit Vectors. 2013;6:34.","journal-title":"Parasit Vectors"},{"key":"1496_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00430-014-0339-0","volume":"203","author":"E Torres-Morales","year":"2014","unstructured":"Torres-Morales E, Taborda L, Cardona N, De-la-Torre A, Sepulveda-Arias JC, Patarroyo MA, Gomez-Marin JE. Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis. Med Microbiol Immunol. 2014;203:315\u201322.","journal-title":"Med Microbiol Immunol"},{"key":"1496_CR41","doi-asserted-by":"publisher","first-page":"10669","DOI":"10.4238\/2014.December.18.9","volume":"13","author":"NZ Zhang","year":"2014","unstructured":"Zhang NZ, Huang SY, Zhou DH, Xu Y, He JJ, Zhu XQ. Identification and bioinformatics analysis of a putative calcium-dependent protein kinase (CDPK6) from Toxoplasma gondii. Genet Mol Res. 2014;13:10669\u201377.","journal-title":"Genet Mol Res"},{"key":"1496_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-065X.2010.00990.x","volume":"240","author":"LD Sibley","year":"2011","unstructured":"Sibley LD. Invasion and intracellular survival by protozoan parasites. Immunol Rev. 2011;240:72\u201391.","journal-title":"Immunol Rev"},{"key":"1496_CR43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1084\/jem.158.3.670","volume":"158","author":"CF Nathan","year":"1983","unstructured":"Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983;158:670\u201389.","journal-title":"J Exp Med"},{"key":"1496_CR44","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.3128869","volume":"240","author":"Y Suzuki","year":"1988","unstructured":"Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516\u20138.","journal-title":"Science"},{"key":"1496_CR45","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.157.9.4045","volume":"157","author":"TM Scharton-Kersten","year":"1996","unstructured":"Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol. 1996;157:4045\u201354.","journal-title":"J Immunol"},{"key":"1496_CR46","doi-asserted-by":"publisher","first-page":"87S","DOI":"10.1111\/j.1550-7408.1997.tb05800.x","volume":"44","author":"MH Bessieres","year":"1997","unstructured":"Bessieres MH, Swierczynski B, Cassaing S, Miedouge M, Olle P, Sequela JP, Pipy B. Role of IFN-gamma, TNF-alpha, IL-4 and IL-10 in the regulation of experimental Toxoplasma gondii infection. J Eukaryot Microbiol. 1997;44:87S.","journal-title":"J Eukaryot Microbiol"},{"key":"1496_CR47","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.1073\/pnas.1307868110","volume":"110","author":"CR Sturge","year":"2013","unstructured":"Sturge CR, Benson A, Raetz M, Wilhelm CL, Mirpuri J, Vitetta ES, Yarovinsky F. TLR-independent neutrophil-derived IFN-\u03b3 is important for host resistance to intracellular pathogens. Proc Natl Acad Sci U S A. 2013;110:10711\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1496_CR48","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1084\/jem.189.7.1083","volume":"189","author":"GS Yap","year":"1999","unstructured":"Yap GS, Sher A. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J Exp Med. 1999;189:1083\u201392.","journal-title":"J Exp Med"},{"key":"1496_CR49","doi-asserted-by":"publisher","first-page":"374696","DOI":"10.1155\/2009\/374696","volume":"2009","author":"J Matowicka-Karna","year":"2009","unstructured":"Matowicka-Karna J, Dymicka-Piekarska V, Kemona H. Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin Dev Immunol. 2009;2009:374696.","journal-title":"Clin Dev Immunol"},{"key":"1496_CR50","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1073\/pnas.0706663105","volume":"105","author":"DF LaRosa","year":"2008","unstructured":"LaRosa DF, Stumhofer JS, Gelman AE, Rahman AH, Taylor DK, Hunter CA, Turka LA. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc Natl Acad Sci U S A. 2008;105:3855\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1496_CR51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/IAI.62.5.1639-1642.1994","volume":"62","author":"IA Khan","year":"1994","unstructured":"Khan IA, Matsuura T, Kasper LH. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun. 1994;62:1639\u201342.","journal-title":"Infect Immun"},{"key":"1496_CR52","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.159.4.1903","volume":"159","author":"EY Denkers","year":"1997","unstructured":"Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, Caspar P, Heiny S, Sher A. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol. 1997;159:1903\u20138.","journal-title":"J Immunol"},{"key":"1496_CR53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","volume":"149","author":"R Gazzinelli","year":"1992","unstructured":"Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol. 1992;149:175\u201380.","journal-title":"J Immunol"},{"key":"1496_CR54","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.exppara.2010.05.008","volume":"126","author":"AJ Kimberly","year":"2010","unstructured":"Kimberly AJ, Christopher AH. Regulation of CD8+ T cell responses to infection with parasitic protozoa. Exp Parasitol. 2010;126:318\u201325.","journal-title":"Exp Parasitol"},{"key":"1496_CR55","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","volume":"68","author":"PC Sayles","year":"2000","unstructured":"Sayles PC, Gibson GW, Johnson LL. B cells are essential for vaccination- induced resistance to virulent Toxoplasma gondii. Infect Immun. 2000;68:1026\u201333.","journal-title":"Infect Immun"},{"key":"1496_CR56","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1365-3024.1999.00256.x","volume":"21","author":"M Vercammen","year":"1999","unstructured":"Vercammen M, Scorza T, El Bouhdidi A, Van Beeck K, Carlier Y, Dubremetz JF, Verschueren H. Opsonization of Toxoplasma gondii tachyzoites with nonspecific immunoglobulins promotes their phagocytosis by macrophages and inhibits their proliferation in nonphagocytic cells in tissue culture. Parasite Immunol. 1999;21:555\u201363.","journal-title":"Parasite Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1496-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1496-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1496-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1496-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T17:50:44Z","timestamp":1692294644000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1496-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1496-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,18]]},"article-number":"168"}}